Tags

Type your tag names separated by a space and hit enter

New Drug Capsule: Olipudase alfa.
Clin Ther. 2023 Mar 24 [Online ahead of print]CT

Authors+Show Affiliations

Tufts University School of Medicine, Public Health & Community Medicine, 136 Harrison Avenue, Boston, Massachusetts, 02111, United States. Electronic address: paul.beninger@tufts.edu.

Pub Type(s)

Editorial

Language

eng

PubMed ID

36967250

Citation

Beninger, Paul. "New Drug Capsule: Olipudase Alfa." Clinical Therapeutics, 2023.
Beninger P. New Drug Capsule: Olipudase alfa. Clin Ther. 2023.
Beninger, P. (2023). New Drug Capsule: Olipudase alfa. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2023.03.004
Beninger P. New Drug Capsule: Olipudase Alfa. Clin Ther. 2023 Mar 24; PubMed PMID: 36967250.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - New Drug Capsule: Olipudase alfa. A1 - Beninger,Paul, Y1 - 2023/03/24/ PY - 2023/03/07/received PY - 2023/03/07/accepted PY - 2023/3/26/entrez PY - 2023/3/27/pubmed PY - 2023/3/27/medline JF - Clinical therapeutics JO - Clin Ther SN - 1879-114X UR - https://www.unboundmedicine.com/medline/citation/36967250/New_Drug_Capsule:_Olipudase_alfa_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.